Adaptimmune

Announcement: Adaptimmune and Galapagos sign clinical collaboration to develop uza-cel

May 31, 2024 8:00 am EDT

Webcast

Latest News

Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise

Read Press Release View All Press Releases

Corporate Deck

Adaptimmune Corporate Deck June 2024

View Presentation View All Presentations

Investor Relations Contact Information

T: 215-825-9306

IR@adaptimmune.com

For other contact information, please visit the Contact page.